Seres Therapeutics, Inc.
MCRB Real Time Price USDRecent trades of MCRB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MCRB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
MCRB Revenue by Segment or Geography
New patents grants
-
Patent Title: Compositions and methods for treating antibiotic resistance Feb. 04, 2025
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Sep. 10, 2024
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Mar. 05, 2024
-
Patent Title: Methods for treatment of clostridium difficile infection or recurrence or symptoms thereof Aug. 22, 2023
-
Patent Title: Compositions and methods for treating cholestatic disease Jul. 18, 2023
-
Patent Title: Network-based microbial compositions and methods Jun. 06, 2023
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 11, 2022
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 04, 2022
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Oct. 04, 2022
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Jul. 19, 2022
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Mar. 08, 2022
-
Patent Title: Compositions and methods for inhibition of pathogenic bacterial growth Nov. 30, 2021
-
Patent Title: Compositions and methods Apr. 13, 2021
-
Patent Title: Compositions and methods Apr. 06, 2021
-
Patent Title: Network-based microbial compositions and methods Jan. 05, 2021
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Dec. 15, 2020
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Apr. 16, 2019
-
Patent Title: Network-based microbial compositions and methods Sep. 18, 2018
-
Patent Title: Compositions and methods Sep. 04, 2018
-
Patent Title: Methods of populating a gastrointestinal tract Sep. 04, 2018
-
Patent Title: Bacterial compositions and methods of use thereof for treatment of immune system disorders May. 01, 2018
-
Patent Title: Compositions and methods Jan. 02, 2018
-
Patent Title: Compositions and methods Mar. 07, 2017
-
Patent Title: Synergistic bacterial compositions and methods of production and use thereof Jan. 03, 2017
-
Patent Title: Compositions and methods Sep. 20, 2016
-
Patent Title: Compositions and methods Nov. 10, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to MCRB
Recent picks made for MCRB stock on CNBC
ETFs with the largest estimated holdings in MCRB
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $MCRB stock a Buy, Sell, or Hold?
- What is the price target for $MCRB stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $MCRB stock?
- Who owns the most shares of $MCRB stock?
- What funds own $MCRB stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MCRB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.